
("Firering" or "the Company")
Quicklime Operations Update
Building quicklime production following successful upgrades
HIGHLIGHTS
· Kiln 1 was successfully upgraded with a new Induced Draft ("ID") fan motor, to achieve a stable throughput of 45-50 tonnes per day ("tpd").
· Refurbishment of Kiln 2 underway with hot commissioning targeted in the coming months and Kilns 3 and 4 to follow, applying operational learnings to optimise efficiency and performance.
· Strong demand pipeline with buying interest across all product categories, supporting additional kilns coming online.
· First sale of lower-grade quicklime, creating value from previously unsaleable material.
· In-house salesperson appointed with extensive Zambian quicklime experience; further product lines under evaluation for local and regional markets.
·
DETAILS
Firering remains focused on scaling up production at Limeco, which is targeting output of between 600 and 800 tonnes of quicklime per day across its eight-kiln plant.
First production from Kiln 1 was achieved in Q1 2025 (see RNS dated
Work on Kiln 2 refurbishment is underway with final equipment being shipped from
Alongside operational progress, Limeco's commercial pipeline continues to strengthen. Buying interest is strong, with demand sufficient to support the additional kilns coming online, and importantly, Limeco now has buyers across all product categories. This was highlighted by a recent sale to a trader for both higher and lower-grade quicklime marking the launch of a new revenue stream from material previously considered unsaleable. To accelerate growth, Limeco has appointed an in-house salesperson with extensive quicklime experience in
Feedstock for Kiln 1 has been drawn from a stockpile exceeding 150,000 tonnes. Looking ahead and having secured a
*** ENDS ***
For further information visit www.fireringplc.com or contact:
|
|
|
T: +44 20 3368 3550
|
|
T: +44 20 7186 9950 |
|
Notes
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the